New Key Statistics Module, Z-Score and F-Score
FRA:HCG Key Ratios
Market Cap € M | 13,287.81 |
Enterprise Value € M | 18,833.65 |
P/E(ttm) | 18.83 |
PE Ratio without NRI | 18.31 |
Forward PE Ratio | -- |
Price/Book | 1.85 |
Price/Sales | 1.95 |
Price/Free Cash Flow | 44.07 |
Price/Owner Earnings | 34.20 |
Payout Ratio % | 1.05 |
Revenue (TTM) € M | 6,701.00 |
EPS (TTM) € | 0.04 |
Beneish M-Score | -2.67 |
10-y EBITDA Growth Rate % | 1.20 |
5-y EBITDA Growth Rate % | -1.60 |
y-y EBITDA Growth Rate % | 10.80 |
EV-to-EBIT | 13.86 |
EV-to-EBITDA | 10.57 |
PEG | -- |
Shares Outstanding M | 18,659.87 |
Net Margin (%) | 10.85 |
Operating Margin % | 14.28 |
Pre-tax Margin (%) | 16.10 |
Quick Ratio | 0.61 |
Current Ratio | 0.68 |
ROA % (ttm) | 3.76 |
ROE % (ttm) | 10.06 |
ROIC % (ttm) | 3.84 |
Dividend Yield % | 5.63 |
Altman Z-Score | 1.22 |
FRA:HCG Number of Guru Trades
FRA:HCG Volume of Guru Trades
Gurus Latest Trades with FRA:HCG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:HCG is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data